Trial Profile
Effect of Smoking Reduction on Endothelial Glucocalyx and Arterial Wall Properites During Medically-aided Smoking Cessation Program
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2022
Price :
$35
*
At a glance
- Drugs Varenicline (Primary) ; Nicotine; Nicotine
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Acronyms SMOKING-VAR-NIC-ATTIKON
- 01 Apr 2020 Planned number of patients changed from 100 to 600.
- 01 Apr 2020 Planned End Date changed from 1 Feb 2015 to 1 Dec 2020.
- 01 Apr 2020 Planned primary completion date changed from 1 Feb 2015 to 30 Nov 2020.